Used as a key intermediate in the synthesis of selective nicotinic acetylcholine receptor modulators, particularly in the development of pharmaceuticals targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its structural features enable effective binding to specific receptor subtypes, enhancing cognitive function and neuronal signaling in preclinical studies. Also employed in research settings to explore cholinergic pathways and develop novel therapeutics with improved selectivity and reduced side effects.